Therapeutics (TGTX) 2025 Earnings Outlook for Investors
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Identify situations where TRI provides a fuller view of performance than a price index, especially when dividends and compounding matter to total returns.
26,863 articlesTG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
ServiceNow stock rose 8.78% over the past week as Reddit traders shift from caution to optimism. The rally follows Nv...
With the Fed chair signaling a hawkish tilt, markets brace for higher-for-longer policy. History suggests the last ti...
Nvidia's CEO argues the AI data-center expansion is only beginning, with trillions more in infrastructure needed. Mar...
A growing cohort of retirees is quietly collecting income from dividend-rich UK stocks, using low-cost funds that bun...
Southern Company is near Dividend Aristocrat territory after two decades of increases, yet a massive five-year capita...
A rare misfire during a live-fire demonstration over Camp Pendleton unleashed shrapnel on California's I-5. The Marin...
A seasoned CEO message can move markets, especially in AI era. This deep dive explains what broadcom hock just delive...
Washington is moving crypto regulation onto a more coordinated, federal framework. A series of cross-agency steps sig...
A federal judge blocked a Pentagon strategy to brand Anthropic as a supply-chain risk and paused a government-wide ba...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
A federal judge weighing future of East Potomac Park golf course is ruling on whether to preserve the public course o...